Table 1 Characteristics of 25 children with pediatric rheumatic diseases treated with Adalimumab.
From: PReS-FINAL-2274: Antiadalimumab antibodies in pediatric rheumatology patients. A pilot experience
AAA | Girls | JIA | ANA+ | Uveitis | Active uveitis | Active arthritis | MTX | Drug switching |
|---|---|---|---|---|---|---|---|---|
Present n = 8 | 6 (75) | 4 (50) | 4 (50) | 8 (100) | 6 (75) | 2 (25) | 2 (25) | 4 (50) |
Absent n = 17 | 13 (77) | 15 (88) | 6 (35) | 13 (77) | 3 (18) | 5 (29) | 6 (35) | 4 (24) |